NIH-funded research R21 grant

Remote collaborative care with contingency management for methamphetamine-related heart and lung disease

Official title: Feasibility and Preliminary Effectiveness of a Remote Collaborative Care-facilitated Contingency Management-Cardiac Rehabilitation Program for People with Methamphetamine-Associated Cardiopulmonary Co

Funded at Utah State Higher Education System--University of Utah · NIH-11422628 · Data updated 2026-11-12

A new program tests a remote care model that combines collaborative medical care with contingency management to help people with methamphetamine-associated heart and lung problems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startJuly 15, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$423,500
NIH project number1R21DA066520-01
Project IDNIH-11422628 on NIH RePORTER

Who could benefit from this research

Could help

Adults with methamphetamine-associated congestive heart failure or methamphetamine-associated pulmonary arterial hypertension who have barriers to in-person care, especially in rural areas.

Less likely to help

Patients without methamphetamine-related cardiopulmonary conditions or those unable to participate in remote care may not benefit.

What this research studies

This project plans to create a remote, integrated care approach for individuals suffering from methamphetamine-associated congestive heart failure and pulmonary arterial hypertension. It uses collaborative care with care management and peer navigation, plus contingency management to encourage ongoing participation in treatment. The plan is to test feasibility and preliminary effectiveness over a 2-year period, focusing on engagement, adherence, and health outcomes in rural populations. If successful, it could lay the groundwork for broader adoption of coordinated addiction and cardiology care for methamphetamine users. Participants would be adults with methamphetamine-related cardiopulmonary conditions and would receive remote, multidisciplinary support.

Why it matters

Potential benefit: If successful, patients could experience better engagement with care, improved heart and lung health, and reduced hospitalizations.

How similar studies have gone: Prior collaborative care models show promise for chronic diseases, but this specific combination for methamphetamine-related heart and lung disease is novel.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Incze, Michael — Utah State Higher Education System--University of Utah
  • Study coordinator: Incze, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.